AnalystsAndres Maldonado
Andres Maldonado's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 11%
#4404 out of 4929 analysts
Average Return
-1.87%
Win Rate
28%27 out of 95
Risk vs Reward
Poor
Good

Andres Maldonado's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Scholar Rock Holding CorpSRRK
+314.00%$8.07$33.41
2024-06-25 -
2025-06-24
Buy
Scholar Rock Holding CorpSRRK
+228.91%$8.06$26.51
2023-10-12 -
2024-10-11
Buy
Scholar Rock Holding CorpSRRK
+215.71%$9.80$30.94
2024-06-04 -
2025-06-03
Buy
Scholar Rock Holding CorpSRRK
+182.30%$10.79$30.46
2024-05-23 -
2025-05-22
Buy
Werewolf Therapeutics IncHOWL
+180.18%$2.17$6.08
2023-03-23 -
2024-03-22
Buy

Andres Maldonado Analyst Color

Get additional color on Andres Maldonado's coverage of popular stocks

Andres Maldonado's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Immunitybio IncIBRX
4Buy$8.00+194.12%Reiterates
a month ago
Aura Biosciences IncAURA
1Buy$22.00+235.37%Assumes
a month ago
Zentalis Pharmaceuticals IncZNTL
1Buy$10.00+693.65%Reiterates
2 months ago
Corbus Pharmaceuticals Holdings IncCRBP
2Buy$40.00+418.81%Maintains
2 months ago
Tscan Therapeutics IncTCRX
1Buy$10.00+562.25%Maintains
2 months ago
Erasca IncERAS
10Buy$6.00+316.67%Reiterates
2 months ago
Foghorn Therapeutics IncFHTX
1Buy$13.00+153.41%Reiterates
2 months ago
Sutro Biopharma IncSTRO
1Hold$2.00+162.12%Reiterates
2 months ago
Protara Therapeutics IncTARA
1Buy$23.00+695.85%Reiterates
2 months ago
Cg Oncology IncCGON
13Buy$75.00+178.81%Reiterates
2 months ago
Day One Biopharmaceuticals IncDAWN
14Buy$36.00+429.41%Reiterates
3 months ago
Mural Oncology PLCMURA
5Buy$6.00+132.56%Maintains
3 months ago
Werewolf Therapeutics IncHOWL
16Buy$15.00+1,301.87%Reiterates
4 months ago
Engene Holdings IncENGN
2Buy$25.00+557.89%Reiterates
4 months ago
Scholar Rock Holding CorpSRRK
13Buy$50.00+38.93%Maintains
7 months ago
Ikena Oncology IncIKNA
11Buy$4.00+200.75%Reiterates
8 months ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.